Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the epigenetics market?

The size of the epigenetics market has seen exponential growth in recent years. It is projected to expand from $10.65 billion in 2024 to $12.83 billion in 2025, with a compound annual growth rate (CAGR) of 20.4%. The substantial growth in the historical period can be credited to the surge in research funding, increase in chronic disease prevalence, the rise of personalized medicine, cancer research, and the aging demographic.

What will be the epigenetics market size in the future?

In the coming years, we anticipate an exponential surge in the size of the epigenetics market. At a compound annual growth rate (CAGR) of 22.7%, it is projected to rise to $29.08 billion by 2029. This growth over the forecast period can be credited to various factors like the development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, regulatory backing, and patient awareness and advocacy. Some of the key trends during this forecast period encompass epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers as well as research into aging and longevity, and the interactions between the microbiome and epigenome.

Get your epigenetics market report here!

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What main drivers are fueling expansion in the epigenetics market?

The escalation in occurrences of cancer and other ailments is playing a major role in propelling the advancement of the epigenetics market. As these diseases become more common, the need for epigenetics correspondingly increases. As an example, the US-based National Cancer Institute (NCI) reported nearly 20 million novel cases of cancer in 2022, which led to roughly 9.7 million fatal incidents. Predictions imply that by 2040, annual new cancer cases will rise to 29.9 million, with fatalities due to cancer hitting 15.3 million. Moreover, the Centers for Disease Control and Prevention (CDC) reports an approximation of 659,000 annual deaths in the United States owing to heart disease. This growing cancer and disease incidence necessitates tests and understanding the alterations in the genes, leading to an inevitable surge in the application and demand of epigenetics. Consequently, the increasing occurrence of cancer and other ailments is propelling the growth of the epigenetics market in the years to come.

What key areas define the segmentation of the global epigenetics market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Who are the dominant players expanding their reach in the epigenetics market?

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

How are evolving market trends shaping epigenetics Strategies?

Prominent enterprises operating in the epigenetics market are prioritizing the creation of advanced technological solutions like DNA sequencing techniques. These solutions aim to augment precision medicine and the understanding and outcomes of disease treatment. DNA sequencing methods, which identify the nucleotide sequence in a DNA molecule, allow for intricate genetic analysis. This gathered data is vital in the detection of genetic variations associated with diseases, fostering the progress of precision medicine. For example, in March 2023, Illumina Inc., an American biotech firm, introduced the Illumina Complete Long Read Technology. This technology facilitates both long-read and short-read sequencing on one instrument, remarkably broadening the scope of genomic research. By lowering DNA input requirements and streamlining workflow, it demystifies the process of library preparation, enabling its use for challenging samples. This technology ensures high accuracy in variant calling, delivering dependable data that is key for thorough genomic analysis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

Which regions are emerging as leaders in the epigenetics market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Cancer Tumor Profiling Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: